Cargando…
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes
BACKGROUND: Depression is prevalent in primary biliary cholangitis (PBC) patients. Our aims were to examine the effects of depression and antidepressants on hepatic outcomes of PBC patients. METHODS: We used the UK Health Improvement Network database to identify PBC patients between 1974 and 2007. O...
Autores principales: | Shaheen, Abdel-Aziz, Kaplan, Gilaad G., Almishri, Wagdi, Vallerand, Isabelle, Frolkis, Alexandra D., Patten, Scott, Swain, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884515/ https://www.ncbi.nlm.nih.gov/pubmed/29617396 http://dx.doi.org/10.1371/journal.pone.0194839 |
Ejemplares similares
-
The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice
por: Almishri, Wagdi, et al.
Publicado: (2019) -
The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the Mouse
por: Almishri, Wagdi, et al.
Publicado: (2021) -
Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study
por: Vallerand, Isabelle A, et al.
Publicado: (2018) -
Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study
por: Shaheen, Abdel Aziz, et al.
Publicado: (2023) -
The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
por: Davis, Rachelle Paige, et al.
Publicado: (2020)